Review: could Aromasin cause Short-term Memory Loss?


Summary

Short-term memory loss is found among people who take Aromasin, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Zometa, and have Breast cancer . We study 7,348 people who have side effects while taking Aromasin from FDA and social media. Among them, 196 have Short-term memory loss. Find out below who they are, when they have Short-term memory loss and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Aromasin

Aromasin has active ingredients of exemestane. It is often used in breast cancer. (latest outcomes from Aromasin 7,501 users)

Short-term Memory Loss

Short-term memory loss has been reported by people with confusional state, weakness, diarrhea, memory loss, fatigue (latest reports from 101,368 Short-term memory loss patients).

On Sep, 18, 2016

7,348 people reported to have side effects when taking Aromasin.
Among them, 196 people (2.67%) have Short-term Memory Loss


Number of reports submitted per year:

Could Aromasin cause Short-term memory loss?

Time on Aromasin when people have Short-term Memory Loss *:

  • < 1 month: 6.25 %
  • 1 - 6 months: 62.5 %
  • 6 - 12 months: 18.75 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 6.25 %
  • 5 - 10 years: 6.25 %
  • 10+ years: 0.0 %

Gender of people who have Short-term Memory Loss when taking Aromasin *:

  • female: 90.62 %
  • male: 9.38 %

Age of people who have Short-term Memory Loss when taking Aromasin *:

  • 0-1: 0.58 %
  • 2-9: 0.58 %
  • 10-19: 1.17 %
  • 20-29: 0.58 %
  • 30-39: 0.0 %
  • 40-49: 13.45 %
  • 50-59: 29.24 %
  • 60+: 54.39 %

Severity if Short-term Memory Loss when taking Aromasin **:

  • least: 0.0 %
  • moderate: 100 %
  • severe: 0.0 %
  • most severe: 0.0 %

How people recovered from Short-term Memory Loss **:

  • while on drug: 0.0 %
  • after off the drug: 0.0 %
  • not yet: 100 %

Top conditions involved for these people *:

  • Breast Cancer (85 people, 43.37%)
  • Breast Cancer Metastatic (46 people, 23.47%)
  • Metastases To Bone (32 people, 16.33%)
  • Pain (22 people, 11.22%)
  • Hypercalcaemia (21 people, 10.71%)

Top co-used drugs for these people *:

  • Zometa (118 people, 60.20%)
  • Aredia (78 people, 39.80%)
  • Femara (68 people, 34.69%)
  • Faslodex (62 people, 31.63%)
  • Xanax (60 people, 30.61%)

Top other side effects for these people *:

  • Pain (121 people, 61.73%)
  • Anxiety (119 people, 60.71%)
  • Arthralgia (113 people, 57.65%)
  • Osteonecrosis Of Jaw (106 people, 54.08%)
  • Bone Disorder (99 people, 50.51%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Short-term memory loss when taking Aromasin?

Browse all side effects of Aromasin

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Short-term memory loss

Short-term memory loss

Could your condition cause Short-term memory loss

Short-term memory loss

Related studies

Can you answer these questions?

More questions for: Aromasin, Short-term memory loss

You may be interested in these reviews

More reviews for: Aromasin, Short-term memory loss


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.